EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

The impact of early perioperative heparin-free anticoagulation for extracorporeal membrane oxygenation on bleeding and thrombotic events in lung transplantation: a retrospective cohort study

Zhijiang Qi, Sichao Gu, Xin Yu, Zeyu Zhang, Xiaoyang Cui, Changlong Li, Min Li, Qingyuan Zhan iD

Therapeutic Advances in Respiratory Disease · 2024-01 · 18

DOI: 10.1177/17534666241273012 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 20.08.2024. Verfasst von Zhijiang Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Lung Transplantation, Anticoagulants, Thrombosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Spontaneous study of the China-Japan Friendship Hospital, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Perioperative heparin-free anticoagulation extracorporeal membrane oxygenation (ECMO) for lung transplantation is rarely reported.

Objective

To evaluate the impact of a heparin-free strategy on bleeding and thrombotic events, blood transfusion, and coagulation function during the early perioperative period and on prognosis, and to observe its effect on different ECMO types.

Design

A retrospective cohort study.

Methods

Data were collected from 324 lung transplantation patients undergoing early perioperative heparin-free ECMO between August 2017 and July 2022. Clinical data including perioperative bleeding and thrombotic events, blood product transfusion, coagulation indicators and 1-year survival were analysed.

Results

Patients were divided in venovenous (VV; n = 251), venoarterial (VA; n = 40) and venovenous-arterial (VV-A; n = 33) groups. The VV group had the lowest intraoperative bleeding and thoracic drainage within 24 h postoperatively. Vein thrombosis occurred in 30.2% of patients within 10 days postoperatively or 1 week after ECMO withdrawal, and no significant difference was found among the three groups. Double lung transplantation, increased intraoperative bleeding, and increased postoperative drainage were associated with vein thrombosis. Except for acute myocardial infarction in one patient, no other serious thrombotic events occurred. The VV-ECMO group had the lowest demand for blood transfusion. The highest prothrombin time and the lowest fibrinogen levels were observed in the VA group during ECMO run, while the highest platelet counts were found in the VV group. Both intraoperative bleeding and thoracic drainage within 24 h postoperatively were independent predictors for 1-year survival, and no thrombosis-related deaths occurred.

Conclusion

Short-term heparin-free anticoagulation, particularly VV-ECMO, did not result in serious thrombotic events or thrombosis-related deaths, indicating that it is a safe and feasible strategy for perioperative ECMO in lung transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationLung TransplantationAnticoagulantsThrombosisBlood CoagulationHumansRetrospective StudiesFemaleMaleMiddle AgedAdultTime FactorsTreatment OutcomeRisk FactorsBlood TransfusionHeparinPostoperative HemorrhageBlood Loss, Surgical

Stichwörter der Autor:innen

bleeding and thrombotic eventscoagulation functionextracorporeal membrane oxygenationheparin-free anticoagulationlung transplantation

Substanzen

AnticoagulantsHeparin

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
  • National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, China-Japan Friendship Hospital, Beijing, China.
  • National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.
  • Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No 2, East Yinghua Road, Chaoyang District, Beijing 100029, China.

ORCID-Profile: Qingyuan Zhan

Förderung

  • Spontaneous study of the China-Japan Friendship Hospital
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Qi, Z., Gu, S., Yu, X., Zhang, Z., Cui, X., Li, C., Li, M., & Zhan, Q. (2024). The impact of early perioperative heparin-free anticoagulation for extracorporeal membrane oxygenation on bleeding and thrombotic events in lung transplantation: a retrospective cohort study. Therapeutic Advances in Respiratory Disease, 18. https://doi.org/10.1177/17534666241273012

Vancouver

Qi Z, Gu S, Yu X, Zhang Z, Cui X, Li C, et al. The impact of early perioperative heparin-free anticoagulation for extracorporeal membrane oxygenation on bleeding and thrombotic events in lung transplantation: a retrospective cohort study. Therapeutic Advances in Respiratory Disease. 2024;18. doi:10.1177/17534666241273012

BibTeX
@article{Qi2024,
  author = {Qi, Zhijiang and Gu, Sichao and Yu, Xin and Zhang, Zeyu and Cui, Xiaoyang and Li, Changlong and Li, Min and Zhan, Qingyuan},
  title = {The impact of early perioperative heparin-free anticoagulation for extracorporeal membrane oxygenation on bleeding and thrombotic events in lung transplantation: a retrospective cohort study},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2024},
  volume = {18},
  doi = {10.1177/17534666241273012}
}
Kostenlos starten →